AVIR - Atea Pharmaceuticals, Inc.
NEXT EARNINGS:
Mar 5, 2026
(in 8 days)
EPS Est: $-0.49
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$6.88
DETAILS
HIGH:
$6.88
LOW:
$6.88
MEDIAN:
$6.88
CONSENSUS:
$6.88
UPSIDE:
47.96%
Market Cap:
363.29M
Volume:
436,658
Avg Volume:
444,156
52 Week Range:
2.455-4.8
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.23
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
56
IPO Date:
2020-10-30
EPS (TTM):
-2.00
P/E Ratio:
-1.68
Revenue (TTM):
N/A
Total Assets:
464.67M
Total Debt:
1.64M
Cash & Equiv:
64.70M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-29.6%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.53 | $-0.46 | -15.2% | — | — | — |
| 2025-08-07 | $-0.44 | $-0.46 | +4.3% | — | — | — |
| 2025-05-12 | $-0.40 | $-0.56 | +28.6% | — | — | — |
| 2025-03-06 | $-0.40 | $-0.35 | -14.3% | — | — | — |
| 2024-11-07 | $-0.37 | $-0.50 | +26.0% | — | — | — |
| 2024-08-07 | $-0.48 | $-0.77 | +37.7% | — | — | — |
| 2024-05-14 | $-0.75 | $-0.61 | -23.0% | — | — | — |
| 2024-02-28 | $-0.47 | $-0.44 | -6.8% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 351.37M | 48.63M | 0 | 0 |
| Net Income | (168.38M) | (135.96M) | (115.91M) | 121.19M | (10.95M) | (13.46M) | (9.06M) |
| EPS | -2.00 | -1.63 | -1.39 | 1.46 | -0.13 | -0.16 | -0.90 |
| Total Assets | 464.67M | 594.97M | 666.71M | 772.89M | 863.63M | 22.07M | 34.86M |
| Total Debt | 1.64M | 2.40M | 3.12M | 197,000 | 0 | 0 | 0 |
| Cash & Equivalents | 64.70M | 143.82M | 646.71M | 764.38M | 850.12M | 21.66M | 34.49M |
| Operating Cash Flow | (135.50M) | (85.39M) | (120.98M) | (87.00M) | 296.73M | (12.81M) | (7.91M) |
| Free Cash Flow | (135.50M) | (85.39M) | (122.92M) | (87.01M) | 296.71M | (12.82M) | (7.92M) |
| FCF per Share | -1.61 | -1.02 | -1.48 | -1.05 | 3.60 | -0.16 | -0.78 |
| Book Value | 438.87M | 555.19M | 640.57M | 710.08M | 547.80M | 19.54M | (36.16M) |
| Cash & ST Investments | 454.72M | 578.11M | 646.71M | 764.38M | 850.12M | 21.66M | 34.49M |
| ROC Equity | -0.38 | -0.24 | -0.18 | 0.17 | -0.02 | -0.69 | N/A |